Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin

Experimental Eye Research

Volumn 96, Issue 1, 2012, Pages 36-41

  Sullivan, Timothy A ^a,b   Geisert, Eldon E ^a   Templeton, Justin P ^a   Rex, Tonia S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b GEORGIA SOUTHERN UNIVERSITY   (United States)

Author keywords

Dose; Erythropoietin; Gene therapy; Neuroprotection; Optic nerve crush; Retinal ganglion cells

Indexed keywords

ADENOVIRUS VECTOR; ARGININE; ENHANCED GREEN FLUORESCENT PROTEIN; ERYTHROPOIETIN; ERYTHROPOIETIN R76E; GLUTAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRUSH TRAUMA; DOSE RESPONSE; DRUG EFFICACY; ERYTHROPOIESIS; GENE MUTATION; GLAUCOMA; HEMATOCRIT; MOUSE; NERVE CRUSH; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE CRUSH; OPTIC NERVE INJURY; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA NERVE CELL;

ANIMALS; CELL COUNT; CYTOMEGALOVIRUS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; GENETIC VECTORS; GLAUCOMA; GREEN FLUORESCENT PROTEINS; HEMATOCRIT; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; NERVE CRUSH; OPTIC NERVE INJURIES; RECOMBINANT FUSION PROTEINS; RETINAL GANGLION CELLS;

EID: 84857796123     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.01.006     Document Type: Article

References (44)

1. Banks W.A., Jumbe N.L., Farrell C.L., Niehoff M.L., Heatherington A.C. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur. J. Pharmacol. 2004, 505:93-101.
2. Beirowski B., Babetto E., Coleman M.P., Martin K.R. The wlds gene delays axonal but not somatic degeneration in a rat glaucoma model. Eur. J. Neurosci. 2008, 28:1166-1179.
3. Bien A., Seidenbecher C.I., Bockers T.M., Sabel B.A., Kreutz M.R. Apoptotic versus necrotic characteristics of retinal ganglion cell death after partial optic nerve injury. J. Neurotrauma 1999, 16:153-163.
4. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 2000, 97:10526-10531.
5. Buckingham B.P., Inman D.M., Lambert W., Oglesby E., Calkins D.J., Steele M.R., Vetter M.L., Marsh-Armstrong N., Horner P.J. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 2008, 28:2735-2744.
6. Canola K., Angenieux B., Tekaya M., Quiambao A., Naash M.I., Munier F.L., Schorderet D.F., Arsenijevic Y. Retinal stem cells transplanted into models of late stages of retinitis pigmentosa preferentially adopt a glial or a retinal ganglion cell fate. Invest. Ophthalmol. Vis. Sci. 2007, 48:446-454.
7. Dijk F., Bergen A.A., Kamphuis W. Gap-43 expression is upregulated in retinal ganglion cells after ischemia/reperfusion-induced damage. Exp. Eye Res. 2007, 84:858-867.
8. Ehlers M.D. Deconstructing the axon: Wallerian degeneration and the ubiquitin-proteasome system. Trends Neurosci. 2004, 27:3-6.
9. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassmann M., Remé C.E. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 2002, 8:718-724.
10. Grimm C., Wenzel A., Stanescu D., Samardzija M., Hotop S., Groszer M., Naash M., Gassmann M., Remé C. Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J. Neurosci. 2004, 24:5651-5658.
11. Grimm C., Hermann D.M., Bogdanova A., Hoptop S., Kilic U., Wenzel A., Kilic E., Gassmann M. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. Semin. Cell. Dev. Biol. 2005, 16:531-538.
12. Howell G.R., Libby R.T., Jakobs T.C., Smith R.S., Phalan F.C., Barter J.W., Barbay J.M., Marchant J.K., Mahesh N., Porciatti V., Whitmore A.V., Masland R.H., John S.W. Axons of retinal ganglion cells are insulted in the optic nerve early in dba/2j glaucoma. J. Cell Biol. 2007, 179:1523-1537.
13. Isenmann S., Wahl C., Krajewski S., Reed J.C., Bahr M. Up-regulation of bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur. J. Neurosci. 1997, 9:1763-1772.
14. Jeon C.J., Strettoi E., Masland R.H. The major cell populations of the mouse retina. J. Neurosci. 1998, 18:8936-8946.
15. Juul S.E., Anderson D.K., Li Y., Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 1998, 43:40-49.
16. Juul S.E., McPherson R.J., Farrell F.X., Jolliffe L., Ness D.J., Gleason C.A. Erythropoietin concentrations in cerebrospinal fluid on nonhuman primates and fetal sheep following high-dose recombinant erythropoietin. Biol. Neonate 2004, 85:138-144.
17. Kermer P., Klocker N., Labes M., Bahr M. Inhibition of cpp32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J. Neurosci. 1998, 18:4656-4662.
18. Kermer P., Ankerhold R., Klocker N., Krajewski S., Reed J.C., Bahr M. Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res. Mol. Brain Res. 2000, 85:144-150.
19. Kielczewski J.L., Pease M.E., Quigley H.A. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest. Ophthalmol. Vis. Sci. 2005, 46:3188-3196.
20. King C.E., Rodger J., Bartlett C., Esmaili T., Dunlop S.A., Beazley L.D. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp. Neurol. 2007, 205:48-55.
21. Klocker N., Kermer P., Weishaupt J.H., Labes M., Ankerhold R., Bahr M. Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3'-kinase/protein kinase b signaling. J. Neurosci. 2000, 20:6962-6967.
22. Kretz A., Happold C.J., Marticke J.K., Isenmann S. Erythropoietin promotes regeneration of adult cns neurons via JAK2/STAT3 and PI3K/Akt pathway activation. Mol. Cell Neurosci. 2005, 29:569-579.
23. Leist M., Ghezzi P., Grasso G., Bianchi R., Billa P., Fratelli M., Savino C., Bianchi M., Nielsen J., Gerwien J., Kallunki P., Larsen A.K., Helboe L., Christensen S., Pedersen L.O., Nielsen M., Torup L., Sager T., Sfacteria A., Erbayraktar S., Erbayraktar Z., Gokmen N., Yilmaz O., Cerami-Hand C., Xie Q.W., Coleman T., Cerami A., Brines M. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004, 305:239-242.
24. Levkovitch-Verbin H. Animal models of optic nerve diseases. Eye (Lond) 2004, 18:1066-1074.
25. Levkovitch-Verbin H., Harris-Cerruti C., Groner Y., Wheeler L.A., Schwartz M., Yoles E. Rgc death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest. Ophthalmol. Vis. Sci. 2000, 41:4169-4174.
26. Li Y., Schlamp C.L., Nickells R.W. Experimental induction of retinal ganglion cell death in adult mice. Invest. Ophthalmol. Vis. Sci. 1999, 40:1004-1008.
27. Li Y., Schlamp C.L., Poulsen K.P., Nickells R.W. Bax-dependent and independent pathways of retinal ganglion cell death induced by different damaging stimuli. Exp. Eye Res. 2000, 71:209-213.
28. Libby R.T., Li Y., Savinova O.V., Barter J., Smith R.S., Nickells R.W., John S.W. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005, 1:17-26.
29. Li Y., Semaan S.J., Schlamp C.L., Nickells R.W. Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. BMC Neurosci. 2007, 8:19.
30. Louboutin J.P., Wang L., Wilson J.M. Gene transfer into skeletal muscle using novel AAV serotypes. J. Gene Med. 2005, 7:442-451.
31. Meuth S.G., Bittner S., Ulzheimer J.C., Kleinschnitz C., Kieseier B.C., Wiendl H. Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of neuroprotective and alterative treatment strategies. BioDrugs 2010, 24:317-330.
32. Quigley H.A., Addicks E.M. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch. Ophthalmol. 1981, 99:137-143.
33. Quigley H.A., Addicks E.M., Green W.R., Maumenee A.E. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch. Ophthalmol. 1981, 99:635-649.
34. Rex T.S., Allocca M., Domenici L., Surace E.M., Maguire A.M., Lyubarsky A., Cellerino A., Bennett J., Auricchio A. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol. Ther. 2004, 10:855-861.
35. Rex T.S., Wong Y., Kodali K., Merry S. Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp. Eye Res. 2009, 89:735-740.
36. Raff M.C., Whitmore A.V., Finn J.T. Axonal self-destruction and neurodegeneration. Science 2002, 296:868-871.
37. Rivera V.M., Gao G.P., Grant R.L., Schnell M.A., Zoltick P.W., Rozamus L.W., Clackson T., Wilson J.M. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 2005, 105:1424-1430.
38. Sullivan T., Kodali K., Rex T.S. Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse. Neurochem. Res. 2011, 36:613-618.
39. Sullivan T.A., Geisert E.E., Hines-Beard J., Rex T.S. Systemic AAV-mediated gene therapy preserves retinal ganglion cells and visual function in DBA/2J glaucomatous mice. J. Hum. Gene Ther. 2011, 22:1191-1200.
40. Wang A.L., Yuan M., Neufeld A.H. Degeneration of neuronal cell bodies following axonal injury in wld(s) mice. J. Neurosci. Res. 2006, 84:1799-1807.
41. Weishaupt J.H., Rohde G., Polking E., Siren A.L., Ehrenreich H., Bahr M. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2004, 45:1514-1522.
42. Wang H., Liu Z.L., Zhuang X.T., Wang M.F., Xu L. Neuroprotective effect of recombinant human erythropoietin on optic nerve injury in rats. Chin. Med. J. (Engl) 2009, 122:2008-2012.
43. Zalewska R., Zalewski B., Reszec J., Mariak Z., Zimnoch L., Proniewska-Skretek E. The expressions of fas and caspase-3 in human glaucomatous optic nerve axons. Med. Sci. Monit. 2008, 14:BR274-278.
44. Zhong L., Bradley J., Schubert W., Ahmed E., Adamis A.P., Shima D.T., Robinson G.S., Ng Y.S. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest. Ophthalmol. Vis. Sci. 2007, 48:1212-1218.